• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

理性设计的抗体作为研究淀粉样β寡聚物结构-毒性关系的研究工具。

Rationally Designed Antibodies as Research Tools to Study the Structure-Toxicity Relationship of Amyloid-β Oligomers.

机构信息

Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK.

Department of Chemistry and Life Science, United States Military Academy, West Point, NY 10996, USA.

出版信息

Int J Mol Sci. 2020 Jun 25;21(12):4542. doi: 10.3390/ijms21124542.

DOI:10.3390/ijms21124542
PMID:32630615
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7352524/
Abstract

Alzheimer's disease is associated with the aggregation of the amyloid-β peptide (Aβ), resulting in the deposition of amyloid plaques in brain tissue. Recent scrutiny of the mechanisms by which Aβ aggregates induce neuronal dysfunction has highlighted the importance of the Aβ oligomers of this protein fragment. Because of the transient and heterogeneous nature of these oligomers, however, it has been challenging to investigate the detailed mechanisms by which these species exert cytotoxicity. To address this problem, we demonstrate here the use of rationally designed single-domain antibodies (DesAbs) to characterize the structure-toxicity relationship of Aβ oligomers. For this purpose, we use Zn-stabilized oligomers of the 40-residue form of Aβ (Aβ) as models of brain Aβ oligomers and two single-domain antibodies (DesAb and DesAb), designed to bind to epitopes at residues 18-24 and 34-40 of Aβ, respectively. We found that the DesAbs induce a change in structure of the Zn-stabilized Aβ oligomers, generating a simultaneous increase in their size and solvent-exposed hydrophobicity. We then observed that these increments in both the size and hydrophobicity of the oligomers neutralize each other in terms of their effects on cytotoxicity, as predicted by a recently proposed general structure-toxicity relationship, and observed experimentally. These results illustrate the use of the DesAbs as research tools to investigate the biophysical and cytotoxicity properties of Aβ oligomers.

摘要

阿尔茨海默病与淀粉样蛋白-β肽(Aβ)的聚集有关,导致脑组织中淀粉样斑块的沉积。最近对 Aβ 聚集诱导神经元功能障碍的机制的仔细研究强调了该蛋白质片段的 Aβ 低聚物的重要性。然而,由于这些低聚物的瞬态和异质性质,研究这些物质发挥细胞毒性的详细机制具有挑战性。为了解决这个问题,我们在这里展示了合理设计的单域抗体(DesAbs)用于表征 Aβ 低聚物的结构-毒性关系。为此,我们使用 Zn 稳定的 40 个残基形式的 Aβ(Aβ)的寡聚物作为脑 Aβ 寡聚物的模型,以及两种单域抗体(DesAb 和 DesAb),分别设计用于结合 Aβ 的残基 18-24 和 34-40 的表位。我们发现 DesAbs 诱导 Zn 稳定的 Aβ 寡聚物的结构发生变化,同时增加其大小和溶剂暴露的疏水性。然后,我们观察到这些寡聚物的大小和疏水性的增加在其对细胞毒性的影响方面相互中和,这与最近提出的一般结构-毒性关系的预测一致,并通过实验观察到。这些结果说明了 DesAbs 作为研究工具在研究 Aβ 低聚物的生物物理和细胞毒性特性方面的用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fca/7352524/c5ba078712d7/ijms-21-04542-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fca/7352524/177c945bdb68/ijms-21-04542-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fca/7352524/cb6a9cc35dff/ijms-21-04542-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fca/7352524/85c98b40dc7e/ijms-21-04542-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fca/7352524/9bf1db5fb3e2/ijms-21-04542-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fca/7352524/8fd794c136c3/ijms-21-04542-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fca/7352524/5f97b4b2e381/ijms-21-04542-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fca/7352524/30c37c25948d/ijms-21-04542-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fca/7352524/c5ba078712d7/ijms-21-04542-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fca/7352524/177c945bdb68/ijms-21-04542-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fca/7352524/cb6a9cc35dff/ijms-21-04542-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fca/7352524/85c98b40dc7e/ijms-21-04542-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fca/7352524/9bf1db5fb3e2/ijms-21-04542-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fca/7352524/8fd794c136c3/ijms-21-04542-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fca/7352524/5f97b4b2e381/ijms-21-04542-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fca/7352524/30c37c25948d/ijms-21-04542-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fca/7352524/c5ba078712d7/ijms-21-04542-g008.jpg

相似文献

1
Rationally Designed Antibodies as Research Tools to Study the Structure-Toxicity Relationship of Amyloid-β Oligomers.理性设计的抗体作为研究淀粉样β寡聚物结构-毒性关系的研究工具。
Int J Mol Sci. 2020 Jun 25;21(12):4542. doi: 10.3390/ijms21124542.
2
beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.表达人β-淀粉样前体蛋白的转基因小鼠中的β-淀粉样沉积物具有与阿尔茨海默病中相同的特征。
Neuroscience. 2001;104(2):299-310. doi: 10.1016/s0306-4522(01)00095-1.
3
Rational design of a conformation-specific antibody for the quantification of Aβ oligomers.针对 Aβ 寡聚物进行定量分析的构象特异性抗体的合理设计。
Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13509-13518. doi: 10.1073/pnas.1919464117. Epub 2020 Jun 3.
4
Aβ-oligomers: A potential therapeutic target for Alzheimer's disease.β-淀粉样寡聚体:阿尔茨海默病的潜在治疗靶点。
Int J Biol Macromol. 2023 Jun 1;239:124231. doi: 10.1016/j.ijbiomac.2023.124231. Epub 2023 Mar 28.
5
Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.可分散的淀粉样β蛋白寡聚体、原纤维和纤维代表可扩散但不可溶的聚集物:它们在淀粉样前体蛋白(APP)转基因小鼠中的神经退行性变中的作用。
Neurobiol Aging. 2012 Nov;33(11):2641-60. doi: 10.1016/j.neurobiolaging.2011.12.032. Epub 2012 Feb 2.
6
Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.中性内肽酶过表达可抑制斑块形成,但无法减少人淀粉样前体蛋白转基因小鼠体内致病性β淀粉样寡聚体及相关认知缺陷。
J Neurosci. 2009 Feb 18;29(7):1977-86. doi: 10.1523/JNEUROSCI.2984-08.2009.
7
Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function.寡聚淀粉样β聚集体水平降低的斑块形成小鼠具有完整的记忆功能。
Neuroscience. 2008 Feb 6;151(3):745-9. doi: 10.1016/j.neuroscience.2007.10.054. Epub 2007 Nov 17.
8
Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains.基于植物的嵌合 HPV 病毒样颗粒携带淀粉样蛋白-β表位,可引发能够识别 APP-tg 小鼠和阿尔茨海默病大脑中淀粉样斑块的抗体。
Inflammopharmacology. 2018 Jun;26(3):817-827. doi: 10.1007/s10787-017-0408-2. Epub 2017 Nov 1.
9
Residues 17-20 and 30-35 of beta-amyloid play critical roles in aggregation.β-淀粉样蛋白的第17至20位氨基酸残基和第30至35位氨基酸残基在聚集过程中起关键作用。
J Neurosci Res. 2004 Jan 15;75(2):162-171. doi: 10.1002/jnr.10859.
10
Distinctive contribution of two additional residues in protein aggregation of Aβ42 and Aβ40 isoforms.两种额外残基在 Aβ42 和 Aβ40 异构体蛋白聚集中的独特贡献。
BMB Rep. 2024 Jun;57(6):263-272. doi: 10.5483/BMBRep.2024-0044.

引用本文的文献

1
Antibodies raised against a structurally defined Aβ oligomer mimic protect human iPSC neurons from Aβ toxicity at sub-stoichiometric concentrations.针对结构明确的 Aβ 寡聚体模拟物产生的抗体在亚化学计量浓度下可保护人诱导多能干细胞神经元免受 Aβ 毒性作用。
PLoS One. 2025 Sep 8;20(9):e0331024. doi: 10.1371/journal.pone.0331024. eCollection 2025.
2
Anti-aging properties of the aminosterols of the dogfish shark.角鲨的氨基甾醇的抗衰老特性。
NPJ Aging. 2024 Dec 19;10(1):62. doi: 10.1038/s41514-024-00188-8.
3
Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years.

本文引用的文献

1
Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies.动力学指纹可区分抗 Aβ 抗体的作用机制。
Nat Struct Mol Biol. 2020 Dec;27(12):1125-1133. doi: 10.1038/s41594-020-0505-6. Epub 2020 Sep 28.
2
Rational design of a conformation-specific antibody for the quantification of Aβ oligomers.针对 Aβ 寡聚物进行定量分析的构象特异性抗体的合理设计。
Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13509-13518. doi: 10.1073/pnas.1919464117. Epub 2020 Jun 3.
3
The Future of Anti-Amyloid Trials.抗淀粉样蛋白治疗临床试验的未来。
纳米抗体的发现:过去五年中它们的应用和潜力的全面综述。
J Nanobiotechnology. 2024 Oct 26;22(1):661. doi: 10.1186/s12951-024-02900-y.
4
Inhibition of cytotoxic self-assembly of HEWL through promoting fibrillation by new synthesized α-hydroxycarbamoylphosphinic acids.通过新合成的α-羟基氨基甲酰次膦酸促进纤维化来抑制蛋清溶菌酶的细胞毒性自组装。
RSC Adv. 2024 Oct 1;14(42):31227-31242. doi: 10.1039/d4ra02969k. eCollection 2024 Sep 24.
5
Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies.帕金森病中α-突触核蛋白与膜的相互作用:机制和治疗策略。
Neurobiol Dis. 2024 Oct 15;201:106646. doi: 10.1016/j.nbd.2024.106646. Epub 2024 Aug 22.
6
Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases.错误折叠的蛋白质寡聚物:形成机制、细胞毒性作用以及针对蛋白质错误折叠疾病的药理学方法。
Mol Neurodegener. 2024 Feb 20;19(1):20. doi: 10.1186/s13024-023-00651-2.
7
The Toxicity of Protein Aggregates: New Insights into the Mechanisms.蛋白质聚集物的毒性:对其机制的新认识。
Int J Mol Sci. 2023 Apr 28;24(9):7974. doi: 10.3390/ijms24097974.
8
Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools.利用化学生物学工具解析神经退行性疾病中淀粉样蛋白的结构与形成
Front Chem. 2022 May 12;10:886382. doi: 10.3389/fchem.2022.886382. eCollection 2022.
9
A Brain-Permeable Aminosterol Regulates Cell Membranes to Mitigate the Toxicity of Diverse Pore-Forming Agents.一种脑可渗透的氨基甾体通过调节细胞膜来减轻多种孔形成剂的毒性。
ACS Chem Neurosci. 2022 Apr 20;13(8):1219-1231. doi: 10.1021/acschemneuro.1c00840. Epub 2022 Apr 11.
10
Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment.多价、多特异性和修饰纳米抗体在疾病治疗中的研究进展与应用。
Front Immunol. 2022 Jan 18;12:838082. doi: 10.3389/fimmu.2021.838082. eCollection 2021.
J Prev Alzheimers Dis. 2020;7(3):146-151. doi: 10.14283/jpad.2020.24.
4
Amyloid-β oligomers in cellular models of Alzheimer's disease.阿尔茨海默病细胞模型中的淀粉样β寡聚物。
J Neurochem. 2020 Nov;155(4):348-369. doi: 10.1111/jnc.15030. Epub 2020 May 18.
5
Dynamics of oligomer populations formed during the aggregation of Alzheimer's Aβ42 peptide.阿尔茨海默病 Aβ42 肽聚集过程中形成的寡聚物种群的动力学。
Nat Chem. 2020 May;12(5):445-451. doi: 10.1038/s41557-020-0452-1. Epub 2020 Apr 13.
6
A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Aβ oligomers from Alzheimer's brain.阿尔茨海默病脑源性可溶性 Aβ 寡聚体损伤突触可塑性的机制假说。
J Neurochem. 2020 Sep;154(6):583-597. doi: 10.1111/jnc.15007. Epub 2020 Apr 5.
7
Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer's disease progression.在阿尔茨海默病进展过程中,脑脊液中存在的可溶性聚集物在大小和毒性机制上发生变化。
Acta Neuropathol Commun. 2019 Jul 26;7(1):120. doi: 10.1186/s40478-019-0777-4.
8
The Toxicity of Misfolded Protein Oligomers Is Independent of Their Secondary Structure.错误折叠蛋白寡聚物的毒性与其二级结构无关。
ACS Chem Biol. 2019 Jul 19;14(7):1593-1600. doi: 10.1021/acschembio.9b00324. Epub 2019 Jul 5.
9
Different soluble aggregates of Aβ42 can give rise to cellular toxicity through different mechanisms.不同可溶性 Aβ42 聚集体通过不同的机制引发细胞毒性。
Nat Commun. 2019 Apr 4;10(1):1541. doi: 10.1038/s41467-019-09477-3.
10
Atomic force microscopy for single molecule characterisation of protein aggregation.原子力显微镜用于蛋白质聚集的单分子特征分析。
Arch Biochem Biophys. 2019 Mar 30;664:134-148. doi: 10.1016/j.abb.2019.02.001. Epub 2019 Feb 8.